Ophthalmopathy Clinical Trial
Official title:
Effect Of Reusing the Operative Supplies On Cataract Surgery and Climate Change
Although postoperative infectious endophthalmitis and toxic anterior segment syndrome (TASS) rarely happen, they can threaten sight and are considered complications of intraocular and cataract surgery1. Reusing surgical supplies during cataract surgery, especially in developing countries, will have a treble impact in lowering the financial costs of surgery, the emissions of greenhouse gas, and environmental waste. Nearly half the waste of cataract surgery is recyclable, as reported by a prospective Malaysian study 8. Despite the increasing evidence of reusing the operative supplies, numerous healthcare professionals may be reluctant to consider it due to worries about cross-contamination among patients2. According to the Aravind Eye Care System (AECS) in Tamil Nadu, India, endophthalmitis rated 0.02% in over a million consecutive cataract cases despite the observation that cannulas, irrigation/ aspiration tubing, gowns, surgical gloves, irrigating bottles, as well as topical and intraocular drugs are normally recycled to cut cost and waste3,4. On the other hand, health care plays a key role in climate change, as well as financial and environmental waste2. Cataracts are the leading cause of blindness and visual impairment worldwide, making cataract surgery one of the most performed surgical procedures5. The carbon footprint of cataract surgery, especially phacoemulsification, is a significant research field6-8. In the United Kingdom, cataract surgery releases 180 kg of CO2- equivalents per eye, causing over half of the emissions due to obtaining large disposable medical equipment9. In ACES, phacoemulsification generated 5.9 kg of carbon emissions4. In comparison to the United Kingdom and the United States of America, the cataract surgery's low rates of infection in AECS were accomplished with 1/10 supply costs and 1/20 global warming emissions6. Being the most performed operation, cataract surgery and ophthalmology, in general, can meaningfully influence lowering environmental and economic waste in their surgical services1. The aim of this work is to show if reusing the operative supplies to reduce financial costs, especially in developing countries, and to lower global warming and climate change will affect the rate of postoperative endophthalmitis after cataract surgery
Status | Recruiting |
Enrollment | 2000 |
Est. completion date | November 1, 2023 |
Est. primary completion date | November 1, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 50 Years and older |
Eligibility | Inclusion Criteria: - adults with cataract not diabetics not hypertensive Exclusion Criteria: youngs diabetics hypertensive - |
Country | Name | City | State |
---|---|---|---|
Egypt | Hany Mahmoud | Sohag | |
Egypt | Sohag University | Sohag |
Lead Sponsor | Collaborator |
---|---|
Sohag University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | postoperative complications | rate of occurence of infection | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05414994 -
Assessment of the Ocular Microbiome in Health and Disease
|
||
Completed |
NCT04387292 -
Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic
|
N/A | |
Completed |
NCT05494242 -
Single Superior ILM/ERM Flap for the FTMH.
|
N/A | |
Terminated |
NCT05494229 -
Autologous Blood for Full-thickness Macular Hole
|
N/A | |
Completed |
NCT04982484 -
Reading Speed Improvements in Wet-AMD Patients After Ranibizumab Treatment
|
||
Completed |
NCT04683055 -
Phaco-Trabeculotomy Vs Phaco-Trabeculectomy
|
N/A | |
Recruiting |
NCT06367517 -
Tocilizumab in Corticosteroid-Resistant Graves' Orbitopathy (Thyroid Eye Disease)
|
||
Completed |
NCT03766737 -
Validation of the Utility of an Intelligent Visual Acuity Diagnostic System for Children
|
N/A | |
Recruiting |
NCT04460001 -
Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for (CRVO)
|
Phase 2/Phase 3 | |
Completed |
NCT04917562 -
Refractive Transepithelial Photo-keratectomy (T-PKR) in High Myopia
|
||
Completed |
NCT04771039 -
Ocular Manifestations of Inflammatory Bowel Disease
|
||
Completed |
NCT03492242 -
Immune CHeckpoint Inhibitors Monitoring of Adverse Drug ReAction
|
||
Withdrawn |
NCT04579458 -
Assessment of COVID-19 in Tearfilm
|
||
Completed |
NCT03855462 -
Evaluating Medium-chain Triglycerides as a Temporary Intraocular Tamponading Agent for Retinal Detachment
|
N/A | |
Recruiting |
NCT06293586 -
Comparison Between Peribulbar And Sub-tenon Blocks on Oculocardiac Reflex (OCR) During Pediatric Strabismus Surgery
|
N/A | |
Recruiting |
NCT03611387 -
Artificial Intelligence Screening on Patients With Primary Angle Closure Glaucoma
|
||
Completed |
NCT03499145 -
Validation of the Utility of Ophthalmology Intelligent Diagnostic System
|